Open access
Open access
Powered by Google Translator Translator

M-A | Risk and benefits of wakefulness-promoting drugs in obstructive sleep apnea patients

23 May, 2023 | 12:43h | UTC

Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea: Systematic Review and Network Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: Researchers find best treatment for excessive daytime sleepiness – McMaster University

Commentary: Multiple agents effective for excessive daytime sleepiness but may be discontinued due to side effects, review finds – ACP Internist

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.